Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17018
Country/Region: South Africa
Year: 2016
Main Partner: AgriAIDS
Main Partner Program: South Africa
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $2,486,063 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $445,819
Care: TB/HIV (HVTB) $297,212
Testing: HIV Testing and Counseling (HVCT) $1,000,000
Treatment: Adult Treatment (HTXS) $743,032
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 3,778
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 3,778
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 37,761
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 30,212
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 75,529
HTS_TST Service Delivery Point (Community): Homebased testing 2017 33,989
HTS_TST Service Delivery Point (Community): Index testing 2017 7,553
HTS_TST Service Delivery Point (Community): Mobile testing 2017 30,212
HTS_TST Service Delivery Point (Community): Other 2017 3,775
HTS_TST Sum of Aggregated Age/Sex <15 2017 7,556
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 67,973
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 75,529
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 3,021
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 3,021
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 9,820
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 8,311
TX_CURR Aggregated Age/Sex: <15 Female 2017 103
TX_CURR Aggregated Age/Sex: <15 Male 2017 103
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,013
TX_CURR Aggregated Age/Sex: 15+ Male 2017 811
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,030
TX_CURR Sum of Aggregated Age/Sex <15 2017 206
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,824
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,030
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 91
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 91
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 903
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 725
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,810
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,810
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,834
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,651
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 82
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 82
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 828
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 659
TX_PVLS Numerator: Indication: Routine 2017 496
TX_PVLS Numerator: Indication: Targeted 2017 1,155
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 92
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 92
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 916
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 734
TX_PVLS_den Denominator: Indication: Routine 2017 549
TX_PVLS_den Denominator: Indication: Targeted 2017 1,285
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 92
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 92
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 913
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 732
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,829
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,030
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 103
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 103
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,013
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 811